The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
MHC ligands and peptide motifs: first listing
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Gregersen, P. K., Silver, J., & Winchester, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,599
Rock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
Falk, K., Rötzschke, O., Stevanovié, S., Jung, G., & Rammensee, H.-G. (1991) · Nature · doi:10.1038/351290a0 · Cited by 2,411
Self-citationThree-dimensional structure of the human class II histocompatibility antigen HLA-DR1
Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L., & Wiley, D. C. (1993) · Nature · doi:10.1038/364033a0 · Cited by 2,379
HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus
Todd, J. A., Bell, J. I., & McDevitt, H. O. (1987) · Nature · doi:10.1038/329599a0 · Cited by 2,036
Townsend, A. (1986) · Cell · doi:10.1016/0092-8674(86)90019-x · Cited by 1,699
Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., & Wiley, D. C. (1994) · Nature · doi:10.1038/368215a0 · Cited by 1,555
Parker, K. C., Bednarek, M. A., & Coligan, J. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.1.163 · Cited by 1,370
Natural history of the major histo-compatibility complex
(1987) · Gene · doi:10.1016/0378-1119(87)90412-4 · Cited by 1,271
Cited by
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Self-citationBorrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183
Insulin-Dependent Diabetes Mellitus
Tisch, R., & McDevitt, H. (1996) · Cell · doi:10.1016/s0092-8674(00)81106-x · Cited by 1,150
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Chowell, D., Morris, L. G. T., Grigg, C. M., Weber, J. K., Samstein, R. M., Makarov, V., Kuo, F., Kendall, S. M., Requena, D., Riaz, N., et al. (2018) · Science · doi:10.1126/science.aao4572 · Cited by 1,142
Goulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,116
Reliable prediction of T‐cell epitopes using neural networks with novel sequence representations
Nielsen, M., Lundegaard, C., Worning, P., Lauemøller, S. L., Lamberth, K., Buus, S., Brunak, S., & Lund, O. (2003) · Protein Science · doi:10.1110/ps.0239403 · Cited by 1,074
MECHANISMS OF MHC CLASS I–RESTRICTED ANTIGEN PROCESSING
Pamer, E., & Cresswell, P. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.323 · Cited by 1,008
Human tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
The Influence of HLA Genotype on AIDS
Carrington, M., & O'Brien, S. J. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152346 · Cited by 722
Wills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B., & Sissons, J. G. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7569-7579.1996 · Cited by 688
NATURAL SELECTION AT MAJOR HISTOCOMPATIBILITY COMPLEX LOCI OF VERTEBRATES
Hughes, A. L., & Yeager, M. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.415 · Cited by 671
Molecular Basis of Celiac Disease
Sollid, L. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.53 · Cited by 643
The chicken B locus is a minimal essential major histocompatibility complex
Kaufman, J., Milne, S., Göbel, T. W. F., Walker, B. A., Jacob, J. P., Auffray, C., Zoorob, R., & Beck, S. (1999) · Nature · doi:10.1038/44856 · Cited by 637
Antigen processing by the proteasome
Kloetzel, P.-M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35056572 · Cited by 637
Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
Sette, A., & Sidney, J. (1999) · Immunogenetics · doi:10.1007/s002510050594 · Cited by 635
Abelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J., Lane, W., Zhang, G. L., Eisenhaure, T. M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 617
ANTIGEN PROCESSING AND PRESENTATION BY THE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX
York, I. A., & Rock, K. L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.369 · Cited by 610
The Sizes of Peptides Generated from Protein by Mammalian 26 and 20 S Proteasomes
Kisselev, A. F., Akopian, T. N., Woo, K. M., & Goldberg, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3363 · Cited by 573
Blachere, N. E., Li, Z., Chandawarkar, R. Y., Suto, R., Jaikaria, N. S., Basu, S., Udono, H., & Srivastava, P. K. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1315 · Cited by 556
Price, P., Witt, C., Allock, R., Sayer, D., Garlepp, M., Kok, C. C., French, M., Mallal, S., & Christiansen, F. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01398.x · Cited by 536
York, I. A., Chang, S.-C., Saric, T., Keys, J. A., Favreau, J. M., Goldberg, A. L., & Rock, K. L. (2002) · Nature Immunology · doi:10.1038/ni860 · Cited by 511
Sarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 499
Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.277 · Cited by 493
Valmori, D., Fonteneau, J.-F., Lizana, C. M., Gervois, N., Liénard, D., Rimoldi, D., Jongeneel, V., Jotereau, F., Cerottini, J.-C., & Romero, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1750 · Cited by 483
Huber, E. M., Basler, M., Schwab, R., Heinemeyer, W., Kirk, C. J., Groettrup, M., & Groll, M. (2012) · Cell · doi:10.1016/j.cell.2011.12.030 · Cited by 483
Petersdorf, E. W., Gooley, T. A., Anasetti, C., Martin, P. J., Smith, A. G., Mickelson, E. M., Woolfrey, A. E., & Hansen, J. A. (1998) · Blood · doi:10.1182/blood.v92.10.3515 · Cited by 480
Acquired resistance to immunotherapy and future challenges
Restifo, N. P., Smyth, M. J., & Snyder, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.2 · Cited by 467
Kelleher, A. D., Long, C., Holmes, E. C., Allen, R. L., Wilson, J., Conlon, C., Workman, C., Shaunak, S., Olson, K., Goulder, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.375 · Cited by 448
Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma
Bloom, M. B., Perry-Lalley, D., Robbins, P. F., Li, Y., El-Gamil, M., Rosenberg, S. A., & Yang, J. C. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.453 · Cited by 401
Cancer vaccines based on the identification of genes encoding cancer regression antigens
Rosenberg, S. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)84664-6 · Cited by 386
Reche, P., Glutting, J.-P., Zhang, H., & Reinherz, E. (2004) · Immunogenetics · doi:10.1007/s00251-004-0709-7 · Cited by 386
Prediction of CTL epitopes using QM, SVM and ANN techniques
Bhasin, M., & Raghava, G. P. S. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.02.005 · Cited by 384
Tumor‐specific shared antigenic peptides recognized by human T cells
Van Der Bruggen, P., Zhang, Y., Chaux, P., Stroobant, V., Panichelli, C., Schultz, E. S., Chapiro, J., Van den Eynde, B. J., Brasseur, F., & Boon, T. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18806.x · Cited by 378
Chemistry of peptides associated with MHC class I and class II molecules
Rammensee, H.-G. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80033-6 · Cited by 365
Self-citationUse of overlapping peptide mixtures as antigens for cytokine flow cytometry
Maecker, H. T., Dunn, H. S., Suni, M. A., Khatamzas, E., Pitcher, C. J., Bunde, T., Persaud, N., Trigona, W., Fu, T.-M., Sinclair, E., et al. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00416-1 · Cited by 356
Dessen, A., Lawrence, C. M., Cupo, S., Zaller, D. M., & Wiley, D. C. (1997) · Immunity · doi:10.1016/s1074-7613(00)80369-6 · Cited by 354
Zhao, J., Zhao, J., & Perlman, S. (2010) · Journal of Virology · doi:10.1128/jvi.01049-10 · Cited by 340
Protein degradation and the generation of MHC class I-presented peptides
Rock, K. L., York, I. A., Saric, T., & Goldberg, A. L. (2002) · Advances in Immunology · doi:10.1016/s0065-2776(02)80012-8 · Cited by 339
Strategies for designing and optimizing new generation vaccines
Berzofsky, J. A., Ahlers, J. D., & Belyakov, I. M. (2001) · Nature Reviews Immunology · doi:10.1038/35105075 · Cited by 334
Progression of autoimmune diabetes driven by avidity maturation of a T-cell population
Amrani, A., Verdaguer, J., Serra, P., Tafuro, S., Tan, R., & Santamaria, P. (2000) · Nature · doi:10.1038/35021081 · Cited by 332
Prediction of MHC class I binding peptides, using SVMHC
Dönnes, P., & Elofsson, A. (2002) · BMC Bioinformatics · doi:10.1186/1471-2105-3-25 · Cited by 330
Buus, S., Lauemøller, S. L., Worning, P., Kesmir, C., Frimurer, T., Corbet, S., Fomsgaard, A., Hilden, J., Holm, A., & Brunak, S. (2003) · Tissue Antigens · doi:10.1034/j.1399-0039.2003.00112.x · Cited by 329
Chang, S.-C., Momburg, F., Bhutani, N., & Goldberg, A. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500721102 · Cited by 326
Molldrem, J., Dermime, S., Parker, K., Jiang, Y., Mavroudis, D., Hensel, N., Fukushima, P., & Barrett, A. (1996) · Blood · doi:10.1182/blood.v88.7.2450.bloodjournal8872450 · Cited by 325
ESCAPE OF HUMAN IMMUNODEFICIENCY VIRUS FROM IMMUNE CONTROL
McMichael, A. J., & Phillips, R. E. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.271 · Cited by 323
Serological identification of human tumor antigens
Sahin, U., Türeci, Ö., & Pfreundschuh, M. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80053-2 · Cited by 315
Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen
Wang, R.-F., Wang, X., Atwood, A. C., Topalian, S. L., & Rosenberg, S. A. (1999) · Science · doi:10.1126/science.284.5418.1351 · Cited by 300
Human tumor antigens for cancer vaccine development
Wang, R., & Rosenberg, S. A. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01331.x · Cited by 296
Beninga, J., Rock, K. L., & Goldberg, A. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18734 · Cited by 296
Fogdell‐Hahn, A., Ligers, A., Grønning, M., Hillert, J., & Olerup, O. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550205.x · Cited by 295
Definition of supertypes for HLA molecules using clustering of specificity matrices
Lund, O., Nielsen, M., Kesmir, C., Petersen, A. G., R�der, G., Justesen, S., Lundegaard, C., Worning, P., Sylvester-Hvid, C., Lamberth, K., et al. (2004) · Immunogenetics · doi:10.1007/s00251-004-0647-4 · Cited by 292
Brusic, V, Rudy, G., Honeyman, G., Hammer, J., & Harrison, L. (1998) · Bioinformatics · doi:10.1093/bioinformatics/14.2.121 · Cited by 292
Tanoka, K., & Kasahara, M. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01195.x · Cited by 282
The role of the proteasome in the generation of MHC class I ligands and immune responses
Sijts, E. J. A. M., & Kloetzel, P.-M. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0657-y · Cited by 280
T-cell epitope mapping by flow cytometry
Kern, F., Surel, I. P., Brock, C., Freistedt, B., Radtke, H., Scheffold, A., Blasczyk, R., Reinke, P., Schneider-Mergener, J., Radbruch, A., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-975 · Cited by 278
Braud, V. M., Allan, D. S. J., Wilson, D., & McMichael, A. J. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70014-4 · Cited by 277
Kern, F., Surel, I. P., Faulhaber, N., Frömmel, C., Schneider-Mergener, J., Schönemann, C., Reinke, P., & Volk, H.-D. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8179-8184.1999 · Cited by 277
Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer, H., Vogt, A. B., Moldenhauer, G., Hammer, J., Blum, J. S., & Hämmerling, G. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01002.x · Cited by 273
Invited anniversary review: HLA associated diseases
Thorsby, E. (1997) · Human Immunology · doi:10.1016/s0198-8859(97)00024-4 · Cited by 272
Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes
Wang, R.-F., Appella, E., Kawakami, Y., Kang, X., & Rosenberg, S. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2207 · Cited by 272
Sjöström, Lundin, Molberg, Körner, Mcadam, Anthonsen, Quarsten, Norén, Roepstorff, Thorsby, et al. (1998) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1998.00397.x · Cited by 269
Karanikas, V, Hwang, L. A., Pearson, J., Ong, C. S., Apostolopoulos, V, Vaughan, H., Xing, P. X., Jamieson, G., Pietersz, G., Tait, B., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119825 · Cited by 263
Blake, N., Lee, S., Redchenko, I., Thomas, W., Steven, N., Leese, A., Steigerwald-Mullen, P., Kurilla, M. G., Frappier, L., & Rickinson, A. (1997) · Immunity · doi:10.1016/s1074-7613(00)80397-0 · Cited by 261
Allen, T. M., Altfeld, M., Yu, X. G., O'Sullivan, K. M., Lichterfeld, M., Le Gall, S., John, M., Mothe, B. R., Lee, P. K., Kalife, E. T., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7069-7078.2004 · Cited by 261
Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
Sidney, J., Grey, H. M., Kubo, R. T., & Sette, A. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80542-1 · Cited by 260
Two complementary methods for predicting peptides binding major histocompatibility complex molecules
Gulukota, K., Sidney, J., Sette, A., & DeLisi, C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0937 · Cited by 259
Gallimore, A. (1998) · Journal of Experimental Medicine · doi:10.1084/jem.187.10.1647 · Cited by 259
Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes.
Topalian, S. L., Gonzales, M. I., Parkhurst, M., Li, Y. F., Southwood, S., Sette, A., Rosenberg, S. A., & Robbins, P. F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.1965 · Cited by 257
Genetic risk factors for inhibitors to factors VIII and IX
OLDENBURG, J., & PAVLOVA, A. (2006) · Haemophilia · doi:10.1111/j.1365-2516.2006.01361.x · Cited by 256
Wang, R. F., Parkhurst, M. R., Kawakami, Y., Robbins, P. F., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1131 · Cited by 255
A Structural Framework for Deciphering the Link Between I-A g7 and Autoimmune Diabetes
Corper, A. L., Stratmann, T., Apostolopoulos, V., Scott, C. A., Garcia, K. C., Kang, A. S., Wilson, I. A., & Teyton, L. (2000) · Science · doi:10.1126/science.288.5465.505 · Cited by 252
MHC Class I Antigens and Immune Surveillance in Transformed Cells
Aptsiauri, N., Cabrera, T., Garcia‐Lora, A., Lopez‐Nevot, M. A., Ruiz‐Cabello, F., & Garrido, F. (2007) · International Review of Cytology · doi:10.1016/s0074-7696(07)56005-5 · Cited by 145
McVay (1996) · doi:10.1084/jem.184.4.1585 · Cited by 138
Peptide-based vaccine for cancer therapies
Buonaguro, L., & Tagliamonte, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1210044 · Cited by 110
(1997) · PubMed · Cited by 103
Zinsli, L. V., Stierlin, N., Loessner, M. J., & Schmelcher, M. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.12.024 · Cited by 63
Naito, T., Ogasawara, H., Kaneko, H., Hishikawa, T., Sekigawa, I., Hashimoto, H., & Maruyama, N. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1025369500466 · Cited by 28
Thioamide Analogues of MHC I Antigen Peptides
Gibadullin, R., Morris, R. K., Niu, J., Sidney, J., Sette, A., & Gellman, S. H. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c05300 · Cited by 17
Metadata
- Authors
- Rammensee, H.-G., Friede, T., & Stevanović, S.
- Venue
- Immunogenetics
- Published
- 1995-02
- Volume
- 41
- Issue
- 4
- Pages
- 178-228
- ISSN
- 0093-7711 (ISSN-L)
- 1432-1211
- OpenAlex
- W2079542677
- Cited by
- 1,638
- References
- 167
- FWCI
- 50.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.